Global EPA & DHA Market - 2023-2030

Global EPA & DHA Market - 2023-2030


The Global EPA & DHA Market reached US$ 1.8 billion in 2022 and is expected to reach US$ 2.9 billion by 2030 and is expected to grow with a CAGR of 6.5% during the forecast period 2023-2030. The EPA and DHA market is witnessing a rising trend in product diversification and innovation. For instance, companies are introducing algae-based EPA and DHA supplements to cater to the growing demand for sustainable and plant-based sources of omega-3s.

The EPA and DHA market is witnessing substantial growth due to the increasing awareness of the health benefits of omega-3 fatty acids. EPA (Eicosapentaenoic Acid) and DHA (Docosahexaenoic Acid) are essential components for supporting cardiovascular and brain health. The market offers various product options, including fish oil, algal oil, and omega-3 supplements, making it convenient for consumers to incorporate these nutrients into their diets.

The rising adoption of omega-3-enriched functional foods is driving the EPA and DHA markets. Food manufacturers are incorporating EPA and DHA into a wide range of fortified food and beverages to cater to health-conscious consumers. For example, there has been an increase in the availability of omega-3-enriched milk, yogurt, and cereals. Moreover, the growing focus on pet health and nutrition has led to the inclusion of EPA and DHA in pet food products, driving the market's expansion in the pet nutrition segment.

Market Dynamics

Global Emphasis on Omega-3 Benefits and Healthcare Recommendations Propel EPA & DHA Market Growth

Health organizations and regulatory bodies worldwide have been emphasizing the importance of omega-3 fatty acids in promoting public health. Governments are implementing policies to encourage the consumption of EPA and DHA through dietary guidelines and public health campaigns. Additionally, regulations are in place to ensure the quality and safety of EPA and DHA products, providing consumers with the assurance of standardized and reliable supplements.

These supportive measures have contributed to increased consumer confidence, thereby boosting the EPA and DHA market trends. Furthermore, the inclusion of omega-3 supplementation in healthcare recommendations and treatment protocols has bolstered market growth. Healthcare professionals are increasingly recommending EPA and DHA supplements to patients with cardiovascular issues, inflammatory conditions, and other health concerns, further driving the demand for these essential fatty acids.

Rising Demand for Plant-Based Sources Propels EPA & DHA Market Growth

With the increasing awareness of sustainability and environmental concerns, there is a growing demand for plant-based sources of EPA and DHA, such as algal oil. Algae-derived omega-3 supplements have gained popularity among vegan and vegetarian consumers who seek an alternative to fish oil. Algal oil offers a sustainable and eco-friendly option, reducing the pressure on marine resources and mitigating the environmental impact of fishing.

As the plant-based movement gains momentum, the demand for EPA and DHA supplements sourced from algae is expected to rise, propelling the growth of the EPA and DHA markets. The market share of algal-based EPA and DHA products is projected to increase in response to changing consumer preferences and ethical considerations.

Contaminant Concerns Pose Challenges to EPA and DHA Market Growth

One of the key restraints of the EPA and DHA market is the potential risk of contaminants in fish oil and marine-based products. As these omega-3 fatty acids are commonly sourced from fish and other marine organisms, there is a possibility of environmental pollutants, heavy metals, and toxins accumulating in their bodies. Contaminants like mercury, PCBs, and dioxins can be present in certain fish species and marine oils, raising concerns among consumers about product safety and potential health risks.

To address this restraint, manufacturers and suppliers in the EPA and DHA market need to implement rigorous quality control measures, such as third-party testing and certifications, to ensure that their products meet safety standards and regulatory requirements. Offering purified and high-quality EPA and DHA supplements can help build consumer trust and overcome this restraint in the market.

COVID-19 Impact Analysis

The COVID-19 Analysis includes Pre-COVID Scenario, COVID Scenario, and Post-COVID Scenario along with Pricing Dynamics (Including pricing change during and post-pandemic comparing it to pre-COVID scenarios), Demand-Supply Spectrum (Shift in demand and supply owing to trading restrictions, lockdown, and subsequent issues), Government Initiatives (Initiatives to revive market, sector or Industry by Government Bodies) and Manufacturers Strategic Initiatives (What manufacturers did to mitigate the COVID issues will be covered here).

Segment Analysis

The global EPA & DHA market has been segmented by type, source, application, and region.

Dietary Supplements Dominate the EPA and DHA Market, Catering to Health-Conscious Consumers

The dietary supplements segment is holding the largest market share, around 45% of the EPA and DHA market. Dietary supplements containing EPA and DHA are widely consumed by individuals seeking to boost their omega-3 intake and improve overall health. These supplements offer a convenient and precise way to obtain the recommended daily dosage of these essential fatty acids.

Additionally, the rising awareness of the health benefits associated with EPA and DHA consumption has contributed to the growth of the dietary supplements segment. Moreover, EPA (Eicosapentaenoic Acid) and DHA (Docosahexaenoic Acid) are prominent types of omega-3 fatty acids found in marine oils, making them the key components of these dietary supplements. Marine oils, sourced from fish and algae, are rich in EPA and DHA, making them ideal for formulating high-quality supplements.

Geographical Analysis

Asia Pacific Emerges as a Growing Force in the EPA & DHA Market, Paving the Way for Expanding Market Share and Size

By region, the global EPA & DHA market is segmented into North America, South America, Europe, Asia-Pacific, Middle-east, and Africa.

The Asia-Pacific region's EPA and DHA market size is experiencing significant growth due to increasing consumer awareness of the health benefits associated with omega-3 fatty acids. Fish oil, algal oil, and omega-3 supplements have gained popularity as they are known to support cardiovascular health and brain function. The rising prevalence of chronic diseases has driven the demand for EPA and DHA products in this region.

As a result, companies are expanding their product offerings to cater to the diverse health needs of consumers. The EPA and DHA market share in the Asia-Pacific region is projected to witness substantial growth as more people embrace preventive healthcare measures. Additionally, the market size is expected to expand as consumers seek personalized and targeted solutions to address their specific health concerns.

Competitive Landscape

The major global players in the market include Koninklijke DSM NV, Corbion N.V., BASF SE, The Archer Daniels Midland Company, Croda International Plc, KD Pharma Group, Lonza Group Ltd., Omega Protein Corporation, GC Rieber Oils AS, and Polaris.

Why Purchase the Report?
• To visualize the global EPA & DHA market segmentation based on type, source, application, and region, as well as understand key commercial assets and players.
• Identify commercial opportunities in the market by analyzing trends and co-development.
• Excel data sheet with numerous data points of EPA & DHA market-level with all segments.
• The PDF report consists of a cogently put-together market analysis after exhaustive qualitative interviews and an in-depth market study.
• Product mapping is available as Excel consists of key products of all the major market players.

The global EPA & DHA market report would provide approximately 61 tables, 62 figures, and 190 Pages.

Target Audience 2023
• Manufacturers/ Buyers
• Industry Investors/Investment Bankers
• Research Professionals
• Emerging Companies


1. Methodology and Scope
1.1. Research Methodology
1.2. Research Objective and Scope of the Report
2. Market Definition and Overview
3. Executive Summary
3.1. Market Snippet, by Type
3.2. Market Snippet, by Source
3.3. Market Snippet, by Application
3.4. Market Snippet, by Region
4. Market Dynamics
4.1. Market Impacting Factors
4.1.1. Drivers
4.1.2. Restraints
4.1.3. Opportunity
4.1.4. Impact Analysis
5. Industry Analysis
5.1. Porter's Five Force Analysis
5.2. Supply Chain Analysis
5.3. Pricing Analysis
5.4. Regulatory Analysis
6. COVID-19 Analysis
6.1. Analysis of COVID-19 on the Market
6.1.1. Scenario Before COVID-19
6.1.2. Scenario During COVID-19
6.1.3. Scenario Post COVID-19
6.2. Pricing Dynamics Amid COVID-19
6.3. Demand-Supply Spectrum
6.4. Government Initiatives Related to the Market During the Pandemic
6.5. Manufacturer’s Strategic Initiatives
6.6. Conclusion
7. By Type
7.1. Introduction
7.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Type
7.1.2. Market Attractiveness Index, By Type
7.2. Eicosapentaenoic Acid (EPA)*
7.2.1. Introduction
7.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
7.3. Docosahexaenoic Acid (DHA)
8. By Source
8.1. Introduction
8.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Source
8.1.2. Market Attractiveness Index, By Source
8.2. Algae Oil*
8.2.1. Introduction
8.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
8.3. Krill oil
8.4. Fish Oil
8.5. Others
9. By Application
9.1. Introduction
9.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
9.1.2. Market Attractiveness Index, By Application
9.2. Infant Formulae*
9.2.1. Introduction
9.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
9.3. Dietary Supplements
9.4. Fortified Food and Beverages
9.5. Pharmaceuticals
9.6. Others
10. By Region
10.1. Introduction
10.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Region
10.1.2. Market Attractiveness Index, By Region
10.2. North America*
10.2.1. Introduction
10.2.2. Key Region-Specific Dynamics
10.2.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Type
10.2.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Source
10.2.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
10.2.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
10.2.6.1. The U.S.
10.2.6.2. Canada
10.2.6.3. Mexico
10.3. Europe
10.3.1. Introduction
10.3.2. Key Region-Specific Dynamics
10.3.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Type
10.3.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Source
10.3.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
10.3.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
10.3.6.1. Germany
10.3.6.2. The U.K.
10.3.6.3. France
10.3.6.4. Italy
10.3.6.5. Spain
10.3.6.6. Rest of Europe
10.4. South America
10.4.1. Introduction
10.4.2. Key Region-Specific Dynamics
10.4.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Type
10.4.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Source
10.4.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
10.4.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
10.4.6.1. Brazil
10.4.6.2. Argentina
10.4.6.3. Rest of South America
10.5. Asia-Pacific
10.5.1. Introduction
10.5.2. Key Region-Specific Dynamics
10.5.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Type
10.5.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Source
10.5.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
10.5.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
10.5.6.1. China
10.5.6.2. India
10.5.6.3. Japan
10.5.6.4. Australia
10.5.6.5. Rest of Asia-Pacific
10.6. Middle East and Africa
10.6.1. Introduction
10.6.2. Key Region-Specific Dynamics
10.6.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Type
10.6.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Source
10.6.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
11. Competitive Landscape
11.1. Competitive Scenario
11.2. Market Positioning/Share Analysis
11.3. Mergers and Acquisitions Analysis
12. Company Profiles
12.1. BASF SE
12.1.1. Company Overview
12.1.2. Product Portfolio and Description
12.1.3. Financial Overview
12.1.4. Key Developments
12.2. Koninklijke DSM NV
12.3. Corbion N.V.
12.4. The Archer Daniels Midland Company
12.5. Croda International Plc
12.6. KD Pharma Group
12.7. Lonza Group Ltd.
12.8. Omega Protein Corporation
12.9. GC Rieber Oils AS
12.10. Polaris
LIST NOT EXHAUSTIVE
13. Appendix
13.1. About Us and Services
13.2. Contact Us

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook
Cookie Settings